Read the Journal of Managed Care + Specialty Pharmacy (JMCP) March 2025 Issue
Best Practice Handout – Health Plan Best Practice – Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)
Summary Framework for Improving Precision Oncology in NSCLC Findings From The AMCP Market Insights Program
The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
For more disease state research, view the Market Insights Program.
Related
View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
